Combined Therapeutic Effects of Vinblastine and Astragalus Saponins in Human Colon Cancer Cells and Tumor Xenograft via Inhibition of Tumor Growth and Proangiogenic Factors

REFERENCES

• Takatsuka S, Yamada N, Sawada T, Ogawa Y, Maeda K, et al.: Contribution of angiogenesis to the progression of colon cancer: possible inhibitory effect of angiogenesis inhibitor TNP-470 on tumor growth and hepatic metastasis. Int J Oncol 17,253–258, 2000.
   PubMed Web of Science ®Google Scholar
• Pluijm G, Löwik C, and Papapoulos S: Tumour progression and angiogenesis in bone metastasis from breast cancer: new approaches to an old problem. Cancer Treat Rev 26,11–27, 2000.
   PubMed Web of Science ®Google Scholar
• van Moorselaar RJ and Voest EE: Angiogenesis in prostate cancer: its role in disease progression and possible therapeutic approaches. Mol Cell Endocrinol 29,239–250, 2002.
   Web of Science ®Google Scholar
• Fukumura D, Xavier R, and Sugiura T: Tumor induction of VEGF promoter activity in stromal cells. Cell 94,715–725, 1998.
   PubMed Web of Science ®Google Scholar
• Hanahan D and Folkman J: Patterns and emerging mechanisms of the angiogenic switch during tumorigenesis. Cell 86,353–364, 1996.
   PubMed Web of Science ®Google Scholar
• Takebayashi Y, Aklyama S, Yamada K, Akiba S, and Aikou T: Angiogenesis as an unfavorable prognostic factor in human colorectal carcinoma. Cancer 78,226–231, 1996.
   PubMed Web of Science ®Google Scholar
• Ellis LM, Takahashi Y, Liu W, and Shaheen RM: Vascular endothelial growth factor in human colon cancer: biology and therapeutic implications. Oncologist 5(Suppl. 1),11–15, 2000.
   PubMedGoogle Scholar
• Egeblad M and Werb Z: New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer 2,161–174, 2002.
   PubMed Web of Science ®Google Scholar
• Tutton MG, George ML, Eccles SA, Burton S, Swift RI, et al.: Use of plasma MMP-2 and MMP-9 levels as a surrogate for tumour expression in colorectal cancer patients. Int J Cancer 107,541–550, 2003.
   PubMed Web of Science ®Google Scholar
• Olmsted JB and Borisy GG: Microtubules. Ann Rev Biochem 42,507–540, 1973.
   PubMed Web of Science ®Google Scholar
• Wilson L: Microtubules as drug receptors: pharmacological properties of microtubule protein. Ann N Y Acad Sci 253,213–231, 1975.
   PubMed Web of Science ®Google Scholar
• Huang Y, Fang Y, Wu J, Dziadyk JM, Zhu X, et al.: Regulation of Vinca alkaloid-induced apoptosis by NF-κB/IκB pathway in human tumor cells. Mol Cancer Ther 3,271–277, 2004.
   PubMed Web of Science ®Google Scholar
• van Tellingen O, Beijnen JH, Nooijen WJ, and Bult A: Plasma pharmacokinetics of vinblastine and the investigational Vinca alkaloid ω-(deacetyl-o-4-vinblastoyl-2,3) -L-ethyl isoleucinate in mice as determined by high-performance liquid chromatography. Cancer Res 53,2061–2065, 1993.
   PubMed Web of Science ®Google Scholar
• Duflos A, Kruczynski A, and Barret JM: Novel aspects of natural and modified Vinca alkaloids. Curr Med Chem 2,55–70, 2002.
   Google Scholar
• Tsai TH: Analytical approaches for traditional Chinese medicines exhibiting antineoplastic activity. J Chromatogr B Biomed Sci Appl 764,27–48, 2001.
   PubMed Web of Science ®Google Scholar
• Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, et al.: Antiangiogenesis is produced by nontoxic doses of vinblastine. Blood 94,4143–4155, 1999.
   PubMed Web of Science ®Google Scholar
• Marimpietri D, Brignole C, Nico B, Pastorino F, Pezzolo A, et al.: Combined therapeutic effects of vinblastine and rapamycin on human neuroblastoma growth, apoptosis, and angiogenesis. Clin Cancer Res 13,3977–3988, 2007.
   PubMed Web of Science ®Google Scholar
• Chen JK and Chen TT: Chinese medical herbology and pharmacology. City of Industry, CA : Art of Medicine Press, 2004.
   Google Scholar
• Tin MM, Cho CH, Chan K, James AE, and Ko JK: Astragalus saponins induce growth inhibition and apoptosis in human colon cancer cells and tumor xenograft. Carcinogenesis 28,1347–1355, 2007.
   PubMed Web of Science ®Google Scholar
• Auyeung KK, Cho CH, and Ko JK: A novel anticancer effect of Astragalus saponins: transcriptional activation of NSAID-activated gene. Int J Cancer 125,1082–1091, 2009.
   PubMed Web of Science ®Google Scholar
• Auyeung KK, Law PC, and Ko JK: Astragalus saponins induce apoptosis via an ERK-independent NF-kappaB signaling pathway in the human hepatocellular HepG2 cell line. Int J Mol Med 23,189–196, 2009.
   PubMed Web of Science ®Google Scholar
• Ma XQ, Shi Q, Duan JA, Dong TT, and Tsim KW: Chemical analysis of Radix Astragali (Huangqi) in China: a comparison with its adulterants and seasonal variations. J Agric Food Chem 50,4861–4866, 2002.
   PubMed Web of Science ®Google Scholar
• Wang YP, Li XY, Song CQ, and Hu ZB: Effect of astragaloside IV on T, B lymphocyte proliferation and peritoneal macrophage function in mice. Acta Pharmacol Sin 23,263–266, 2002.
   PubMed Web of Science ®Google Scholar
• Albini A, Iwamoto Y, Kleinman HK, Martin GR, Aaronson SA, et al.: A rapid in vitro assay for quantitating the invasive potential of tumor cells. Cancer Res 47,3239–3245, 1987.
   PubMed Web of Science ®Google Scholar
• Freeman SL and MacNaughton WK: Ionizing radiation induces iNOS-mediated epithelial dysfunction in the absence of an inflammatory response. Am J Physiol Gastrointest Liver Physiol 278,G243–G450, 2000.
   Web of Science ®Google Scholar
• Bressin C, Bourgarel-Rey V, Carré M, Pourroy B, Arango D, et al.: Decrease in c-Myc activity enhances cancer cell sensitivity to vinblastine. Anti-Cancer Drugs 17,181–187, 2006.
   PubMed Web of Science ®Google Scholar
• Auyeung KK, Law PC, Chan LY, and Ko JK: Astragalus saponins downregulate hypoxia-induced VEGF induction in colon cancer cells. BMC Comp Altern Med 12,160, 2012.
   PubMed Web of Science ®Google Scholar
• Auyeung KK, Mok NL, Wong CM, Cho CH, and Ko JK: Astragalus saponins modulate mTOR and ERK signaling to promote apoptosis through the extrinsic pathway in HT-29 colon cancer cells. Int J Mol Med 26,341–349, 2010.
   PubMed Web of Science ®Google Scholar
• Auyeung KK, Woo PK, Law PC, and Ko JK: Astragalus saponins modulate cell invasiveness and angiogenesis in human gastric adenocarcinoma cells. J Ethnopharmacol 141,635–641, 2012.
   PubMed Web of Science ®Google Scholar
• Yang H, Ganguly A, and Cabral F: Inhibition of cell migration and cell division correlates with distinct effects of microtubule inhibiting drugs. J Biol Chem 285,32242–32250, 2010.
   PubMed Web of Science ®Google Scholar
• Upreti M, Lyle CS, Skaug B, Du L, and Chambers TC: Vinblastine-induced apoptosis is mediated by discrete alterations in subcellular location, oligomeric structure, and activation status of specific Bcl-2 family members. J Biol Chem 281,15941–15950, 2006.
   PubMed Web of Science ®Google Scholar
• Welsh JB, Sapinoso LM, Kern SG, Brown DA, Liu T, et al.: Large-scale delineation of secreted protein biomarkers overexpressed in cancer tissue and serum. Proc Natl Acad Sci USA 100,3410–3415, 2003.
   PubMed Web of Science ®Google Scholar
• Yang H, Park SH, Choi HJ, and Moon Y: The integrated stress response-associated signals modulates intestinal tumor cell growth by NSAID-activated gene 1 (NAG-1/MIC-1/ PTGF-beta). Carcinogenesis 31,703–711, 2010.
   PubMed Web of Science ®Google Scholar
• Harris AL: Angiogenesis as a new target for cancer control. Eur J Cancer 1(Suppl.), 1–12, 2003.
   Web of Science ®Google Scholar
• Kamba T and McDonald DM: Mechanisms of adverse effects of anti-VEGF therapy for cancer. Br J Cancer 96,1788–1795, 2007.
   PubMed Web of Science ®Google Scholar
• Ferrara N and Kerbel RS: Angiogenesis as a therapeutic target. Nature 438,967–974, 2005.
   PubMed Web of Science ®Google Scholar
• Albertsson P, Lennernäs B, and Norrby K: Dose effects of continuous vinblastine chemotherapy on mammalian angiogenesis mediated by VEGF-A. Acta Oncol 47,293–300, 2008.
   PubMed Web of Science ®Google Scholar
• Ribatti D, Guidolin D, Conconi MT, Nico B, Baiguera S, et al.: Vinblastine inhibits the angiogenic response induced by adrenomedullinin vitro and in vivo. Oncogene 22,6458–6461, 2003.
   PubMed Web of Science ®Google Scholar
• Vacca A, Iurlaro M, Ribatti D, Minischetti M, Nico B, et al.: Antiangiogenesisis produced by nontoxic doses of vinblastine. Blood 94,4143–4155, 1999.
   PubMed Web of Science ®Google Scholar
• Carmeliet, P: VEGF as a key mediator of angiogenesis in cancer. Oncology 69,4–10, 2005.
   PubMed Web of Science ®Google Scholar
• Pourgholami MH and Morris DL: Inhibitors of vascular endothelial growth factor in cancer. Cardiovas Hematol Agents Med Chem 6,343–347, 2008.
   PubMedGoogle Scholar
• Gilles C, Polette M, Piette J, Munaut C, Thompson EW, et al.: High level of MT-MMP expression is associated with invasiveness of cervical cancer cells. Int J Cancer 65,209–213, 1996.
   PubMed Web of Science ®Google Scholar
• Coussens LM and Werb Z: Matrix metalloproteinases and the development of cancer. Chem Biol 3,895–904, 1996.
   PubMed Web of Science ®Google Scholar
• Nakahara H: Transmembrane/cytoplasmic domain-mediated membrane type 1-matrix metalloprotease docking to invadopodia is required for cell invasion. Proc Natl Acad Sci USA 94,7959–7964, 1997.
   PubMed Web of Science ®Google Scholar
• Lubbe WJ, Zhou ZY, Fu W, Zuzga D, Schulz S, et al.: Tumor epithelial cell matrix metalloproteinase-9 is a target for antimetastatic therapy in colorectal cancer. Clin Cancer Res 12,1876–1882, 2006.
   PubMed Web of Science ®Google Scholar
• Curran S and Murray GI: Matrix metalloproteinases in tumour invasion and metastasis. J Pathol 189,300–308, 1999.
   PubMed Web of Science ®Google Scholar
• Kitadai Y, Bucana CD, Ellis LM, Anzai H, Tahara E, et al.: In situ mRNA hybridization technique for analysis of metastasis-related gene in human colon carcinoma cells. Am J Pathol 147,1238–1247, 1996.
   Web of Science ®Google Scholar
• Asahara T, Bauters C, and Zheng LP: Synergistic effect of vascular endothelial growth factor and basic fibroblast growth factor on angiogenesis in vivo. Circulation 92,365–371, 1995.
   Web of Science ®Google Scholar
• Shoeib NA, Bibby MC, Blunden G, Linley PA, Swaine DJ, et al.: In vitro cytotoxic activities of the major bromophenols of the red alga Polysiphonialanosa and some novel synthetic isomers. J Nat Prod 67,1445–1449, 2004.
   PubMed Web of Science ®Google Scholar
• Mellor HR, Ferguson DJ, and Callaghan R: A model of quiescent tumour microregions for evaluating multicellular resistance to chemotherapeutic drugs. Br J Cancer 93,302–309, 2005.
   PubMed Web of Science ®Google Scholar
• Alexandrova N, Niklinski J, Bliskovsky V, Otterson GA, Blake M, et al.: The N-terminal domain of c-Myc associates with alpha-tubulin and microtubules in vivo and in vitro. Mol Cell Biol 15,5188–5195, 1995.
   PubMed Web of Science ®Google Scholar
• El Khyari S, Bourgarel V, Barra Y, Braguer D, and Briand C: Pretreatment by tubulin agents decreases c-Myc induction in human colon carcinoma cell line HT29-D4. Biochem Biophys Res Commun 231,751–754, 1997.
   PubMed Web of Science ®Google Scholar
• Bourgarel-Rey V, El Khyari S, Rimet O, Bordas B, Guigal N, et al.: Opposite effects of antimicrotubule agents on c-myc oncogene expression depending on the cell lines used. Eur J Cancer 36,1043–1049, 2000.
   PubMed Web of Science ®Google Scholar
• Bourgarel-Rey V, Vallee S, Rimet O, Champion S, Braguer D, et al.: Involvement of nuclear factor kappaB in c-Myc induction by tubulin polymerization inhibitors. Mol Pharmacol 59,1165–1170, 2001.
   PubMed Web of Science ®Google Scholar
• Huang KC: The pharmacology of Chinese herbs, 2nd ed. Boca Raton, FL : CRC Press, 1999.
   Google Scholar
• Ko JKS and Chik CW: The protective action of radix Astragalus membranaceus against hapten-induced colitis through modulation of cytokines. Cytokine 47,85–90, 2009.
   PubMed Web of Science ®Google Scholar
• Crowell PL: Prevention therapy of cancer by dietary monoterpenes. J Nutr 129,775–778, 1999.
   PubMed Web of Science ®Google Scholar
• Frese S, Pirnia F, Miescher D, Krajewski S, Borner MM, et al.: PG490-mediated sensitization of lung cancer cells to Apo2L/TRAIL-induced apoptosis requires activation of ERK2. Oncogene 22,5427–5435, 2003.
   PubMed Web of Science ®Google Scholar
• Yinjun L, Jie J, and Yungui W: Triptolide inhibits transcription factor NF-kappaB and induces apoptosis of multiple myeloma cells. Leukemia Res 29,99–105, 2005.
   PubMed Web of Science ®Google Scholar
• Amon LA, Pezzuto JM, and Graves JM: Evaluation of the mutagenic, cytotoxic, and antitumor potential of triptolide, a highly oxygenated diterpene isolated from Tripterygium wilfordii. Cancer Lett 112,113–117, 1997.
   PubMed Web of Science ®Google Scholar